JOHNSON & JOHNSON is 298.6x more valuable than OCULAR THERAPEUTIX, INC by market capitalization ($573.71 B vs $1.92 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | OCUL | JNJ |
|---|---|---|
| Market cap | $1.92 B | $573.71 B |
| US-listed rank | #2135 | #20 |
| Revenue (latest FY) | $51.95M | $94.19B |
| Net income (latest FY) | -$265.94M | $26.80B |
| Net margin | -511.9% | 28.5% |
| P/E (trailing FY) | - | 21.4 |
| SEC filings | 827 | 984 |
JOHNSON & JOHNSON is 298.6x more valuable than OCULAR THERAPEUTIX, INC by market capitalization ($573.71 B vs $1.92 B).
In their latest fiscal years, OCULAR THERAPEUTIX, INC reported $51.95M in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: OCULAR THERAPEUTIX, INC and JOHNSON & JOHNSON, or browse the full rankings.